NCT02623699 An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE3
NCT02611674 Methodology Study of Novel Outcome Measures to Assess Progression of ALS Status COMPLETED Phase N/A
NCT02594124 A Study for Participants With Spinal Muscular Atrophy (SMA) Who Previously Participated in Nusinersen (ISIS 396443) Investigational Studies Status COMPLETED Phase PHASE3
NCT02579681 Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012 Status COMPLETED Phase PHASE3
NCT02568111 Brimonidine Tartrate for the Treatment of Injection Related Erythema Status WITHDRAWN Phase PHASE4
NCT02555215 Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) Status COMPLETED Phase PHASE3
NCT02551497 Study to Evaluate the Interaction Between a Drug and CNV1014802 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02525874 Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS). Status COMPLETED Phase PHASE3
NCT02484547 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02477800 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02472938 Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis Status WITHDRAWN Phase PHASE4
NCT02462759 A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA). Status TERMINATED Phase PHASE2
NCT02461069 Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis Status COMPLETED Phase PHASE4